Antagoniści receptorów endotelinowych (ERA) – krótka charakterystyka nowej grupy leków Journal title: Advances in Hygiene and Experimental Medicine Authors: Agata Kowalczyk, Michał Kołodziejczyk, Anna Gorąca Subject(s): Medicine
Endothelin receptor antagonists – a brief description of the new class of drugs Journal title: Advances in Hygiene and Experimental Medicine Authors: Agata Kowalczyk, Michał Kołodziejczyk, Anna Gorąca Subject(s): Medicine
CPU0213, a novel endothelin receptor antagonist, suppresses the upregulation of matrix metalloproteinases and connexin 43 in hyperthyroid myocardium. Journal title: Pharmacological Reports Authors: Xiao-Yun Tang, Qing Liu, De-Zai Dai, Yin Dai Subject(s):
Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy. Journal title: Pharmacological Reports Authors: Yu Feng, De-Zai Dai, Tao Na, Bing Cui, Yuan Zhang, Yin Dai Subject(s):
Senning operation as a palliative therapy for a girl with complex heart defect and Eisenmenger syndrome (RCD code: II‑1A.4d) Journal title: Journal of Rare Cardiovascular Diseases Authors: Jacek Kuźma, Andrzej Rudziński, Grzegorz Kopeć, Piotr Weryński, Dorota Palczewska, Daniel Porada, Ma... Subject(s):
Pulmonary arterial hypertension after systemic‑to‑pulmonary shunt correction (RCD code: II-1A.4d) Journal title: Journal of Rare Cardiovascular Diseases Authors: Magdalena Kaznica-Wiatr, Grzegorz Kopeć, Piotr Podolec Subject(s):